Jesús
Joglar Tamargo
Publications by the researcher in collaboration with Jesús Joglar Tamargo (20)
2015
-
Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats
DMM Disease Models and Mechanisms, Vol. 8, Núm. 10, pp. 1213-1225
2013
-
Dose-dependent metabolic disposition of hydroxytyrosol and formation of mercapturates in rats
Pharmacological Research, Vol. 77, pp. 47-56
2012
-
Unsaturated fatty alcohol derivatives of olive oil phenolic compounds with potential low-density lipoprotein (LDL) antioxidant and antiobesity properties
Journal of Agricultural and Food Chemistry, Vol. 60, Núm. 4, pp. 1067-1074
2011
-
Direct analysis of glucuronidated metabolites of main olive oil phenols in human urine after dietary consumption of virgin olive oil
Food Chemistry, Vol. 126, Núm. 1, pp. 306-314
2010
-
Antioxidant activities of hydroxytyrosol main metabolites do not contribute to beneficial health effects after olive oil ingestion
Drug Metabolism and Disposition, Vol. 38, Núm. 9, pp. 1417-1421
-
Matrix effects on the bioavailability of resveratrol in humans
Food Chemistry, Vol. 120, Núm. 4, pp. 1123-1130
-
Synthesis of fatty acid amides of catechol metabolites that exhibit antiobesity properties
ChemMedChem, Vol. 5, Núm. 10, pp. 1781-1787
2009
-
Enzymatic Synthesis of Glycosides and Glucuronides
Practical Methods for Biocatalysis and Biotransformations (John Wiley & Sons, Ltd), pp. 227-231
-
Neurotoxic thioether adducts of 3,4-methylenedioxymethamphetamine identified in human urine after ecstasy ingestion
Drug Metabolism and Disposition, Vol. 37, Núm. 7, pp. 1448-1455
2008
-
Serotonergic neurotoxic thioether metabolites of 3,4- methylenedioxymethamphetamine (MDMA, "ecstasy"): Synthesis, isolation, and characterization of diastereoisomers
Chemical Research in Toxicology, Vol. 21, Núm. 12, pp. 2272-2279
2006
-
Biocatalyzed synthesis and structural characterization of monoglucuronides of hydroxytyrosol, tyrosol, homovanillic alcohol, and 3-(4′-hydroxyphenyl) propanol
Advanced Synthesis and Catalysis, Vol. 348, Núm. 15, pp. 2155-2162
-
Postprandial LDL phenolic content and LDL oxidation are modulated by olive oil phenolic compounds in humans
Free Radical Biology and Medicine, Vol. 40, Núm. 4, pp. 608-616
2004
-
Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine)
Drug Metabolism and Disposition, Vol. 32, Núm. 9, pp. 1001-1007
2003
-
Quantitative determination of paroxetine and its 4-hydroxy-3-methoxy metabolite in plasma by high-performance liquid chromatography/electrospray ion trap mass spectrometry: Application to pharmacokinetic studies
Rapid Communications in Mass Spectrometry, Vol. 17, Núm. 13, pp. 1455-1461
-
Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry
Rapid Communications in Mass Spectrometry, Vol. 17, Núm. 4, pp. 330-336
-
Synthesis of the major metabolites of Paroxetine
Bioorganic Chemistry, Vol. 31, Núm. 3, pp. 248-258
2002
-
Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis
Journal of Analytical Toxicology, Vol. 26, Núm. 3, pp. 157-165
-
High-performance liquid chromatography with electrochemical detection applied to the analysis of 3,4-dihydroxymethamphetamine in human plasma and urine
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 769, Núm. 2, pp. 313-321
-
Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites
Bioorganic and Medicinal Chemistry, Vol. 10, Núm. 4, pp. 1085-1092
2001
-
3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans
Chemical Research in Toxicology, Vol. 14, Núm. 9, pp. 1203-1208